Toggle Mobile Navigation

Posts Tagged ‘Value-Based Strategies for Reimbursement and Formulary Success’

Expert Insights: Q&A With Patient Access Leader, Melissa L. Paige

ExL’s Value-Based Strategies for Reimbursement and Formulary Success Conference Producer, Mercy Lister, had the opportunity to sit down and discuss some of the issues and challenges facing the industry with the event’s chair, Melissa L. Paige, Oncology Patient Access Principal Coordination at the University of Virginia Health System, NCI-Designated Emily Couric Clinical Cancer Center. See excerpts from the Q&A session below.

Q: How do you collaborate with payers and pharma to get access to the right product at the right time for the right patient?

A: Prior to any product launch, we seek…

READ MORE


Industry Leaders From Pfizer, Merck and Pacira Share Insights at the Value-Based Reimbursement Event!

The methodical challenges faced by market access professionals can vastly differ by therapeutic area, size of the organization, and the number of resources available to them. Cookie-cutter solutions cannot address the unique challenges faced by a company. It is critical that the education available to market access professionals meets the varying needs of the industry. Don’t worry — leaders from Pfizer, Merck, Pacira and more share insights at our Value-Based Reimbursement event.

The speaking faculty at ExL’s Value-Based Strategies for Reimbursement and Formulary Success conference consists of executives from pharmaceutical…

READ MORE


Current Events Prove the Value-Based Reimbursement Summit Is a Can’t-Miss Event!

Since the release of the brochure for ExL’s Value-Based Strategies for Reimbursement and Formulary Success, recent news has emerged, highlighting the pressure placed on life science organizations to account for the healthcare value of drugs in reimbursement strategies. In an era of performance-driven healthcare, we have continued to follow this topic in the news. The below articles address current events in formulary access and reimbursement strategies and highlight the importance of staying up to date with industry developments.

Will the UK’s Post-Brexit Life Sciences Strategy Be a Boon for Market Access?

The highly anticipated life sciences strategy commissioned by the UK government…

READ MORE


live chat software